Emilia Cercenado
Overview
Explore the profile of Emilia Cercenado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
1830
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Penalva G, Canton R, Perez-Rodriguez M, Gonzalez-Lopez J, Rodriguez-Bano J, Barrio-Tofino E, et al.
Lancet Reg Health Eur
. 2025 Feb;
51:101220.
PMID: 39958398
Background: Assessing the burden of antimicrobial resistance is essential to determine the magnitude of this problem and to set its priority. We aimed to estimate the burden of disease caused...
2.
Diaz-Navarro M, Cercenado E, Monte A, Visedo A, Rodriguez C, Perez-Granda M, et al.
Heliyon
. 2025 Jan;
11(2):e41885.
PMID: 39877599
Background: Oritavancin (ORT) is a new single-dose lipoglycopeptide showing activity against staphylococci and vancomycin-resistant enterococci. However, there is no data regarding its potential use as a catheter lock solution are...
3.
Lopez de Egea G, Gonzalez-Diaz A, Olsen R, Guedon G, Berbel D, Grau I, et al.
Int J Infect Dis
. 2025 Jan;
153:107778.
PMID: 39800082
Objectives: An increase in Streptococcus dysgalactiae subsp. equisimilis (SDSE) infections has been documented worldwide. This study aims to analyze invasive disease caused by SDSE (iSDSE) in adults over an 11-year...
4.
Calvo-Silveria S, Gonzalez-Diaz A, Marimon J, Cercenado E, Quesada M, Casabella A, et al.
J Infect Public Health
. 2024 Dec;
18(1):102619.
PMID: 39662160
Background: Streptococcus pneumoniae causes invasive pneumococcal disease (IPD) in adults. The introduction of pneumococcal conjugate vaccines (PCVs) has reduced vaccine serotypes but has also led to the rise of non-vaccine...
5.
Irigoyen-von-Sierakowski A, Ocana A, Sanchez-Mayoral R, Cercenado E
JAC Antimicrob Resist
. 2024 Oct;
6(5):dlae169.
PMID: 39464858
Objectives: Cefiderocol is a novel siderophore-conjugated cephalosporin developed for the treatment of multidrug-resistant Gram-negative bacterial (GNB) infections. However, the current gold standard for cefiderocol susceptibility testing, broth microdilution (BMD) using...
6.
Aguilera-Alonso D, Sanchez-Canete J, Ventura McArdle L, Del Rosal T, Sanz Santaeufemia F, Soto B, et al.
Pediatr Infect Dis J
. 2024 Oct;
44(2):151-153.
PMID: 39417786
This study conducted in Madrid, Spain between 2018 and 2023 shows a significant decrease in the pediatric bacterial community-acquired pneumonia cases during the COVID-19 pandemic, followed by a notable postpandemic...
7.
Lopez-Camacho E, Aguilera-Alonso D, Buenestado-Serrano S, Marin M, Molero-Salinas A, Lopez Fresnena N, et al.
Pediatr Infect Dis J
. 2024 Sep;
44(2):166-173.
PMID: 39348498
Background: Klebsiella michiganensis , a member of the Klebsiella oxytoca complex, is an emerging nosocomial pathogen known to frequently carry plasmids with antibiotic-resistance genes, including carbapenemases. Using genomics, this study...
8.
De la Villa S, Sanchez-Martinez C, Cercenado E, Padilla B, Vicente T, Serrano J, et al.
Int J Antimicrob Agents
. 2024 Sep;
64(5):107318.
PMID: 39233217
Objective: We analyse the effectiveness of short courses of adequate treatment in patients with episodes of carbapenemase-producing Enterobacterales bloodstream-infections (CPE-BSI). Methods: Patients with first monomicrobial CPE-BSI episodes who received ≥72...
9.
Rodriguez-Villodres A, Lepe-Balsalobre E, Ortiz de la Rosa J, Giner Almaraz S, Gonzalez de Herrero E, Cercenado E, et al.
JAC Antimicrob Resist
. 2024 Jun;
6(3):dlae087.
PMID: 38847006
Objectives: To analyse the susceptibility profile to cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations in complex and isolated from intra-abdominal, urinary, respiratory and bloodstream infections in the SMART (Study for...
10.
Dahdouh E, Gomez-Marcos L, Canada-Garcia J, de Arellano E, Sanchez-Garcia A, Sanchez-Romero I, et al.
Front Cell Infect Microbiol
. 2024 May;
14:1390966.
PMID: 38817448
Introduction: Carbapenemase-Producing (CP-Eco) isolates, though less prevalent than other CP-Enterobacterales, have the capacity to rapidly disseminate antibiotic resistance genes (ARGs) and cause serious difficult-to-treat infections. The aim of this study...